On February 7, the FDA cleared LifeScan’s OneTouch VerioSync blood glucose meter. It will feature wireless Bluetooth compatibility with the iPhone, allowing blood...

The newest in CGM: learn about Dexcom’s redesigned, more accurate, and sleeker G4 Platinum system.

On November 8, an FDA advisory panel voted 8-4 to recommend approval of Novo Nordisk’s ultra-long-acting basal insulin degludec (to be marketed under the name “Tresiba...

Frequent and careful blood glucose monitoring is unquestionably useful for people who take insulin, but is monitoring necessary for all patients

Supreme Court Justice Sonia Sotomayor’s incredible journey with type 1 diabetes.

This month, in a surprise move, Vivus announced that its weight management medication Qsymia is now available via mail order through Walmart. This is an addition to the...

Our trip to Orlando brings smart, actionable advice on preventing high and low blood sugars from diabetes guru and educator Mr. Gary Scheiner.

In June, pharmaceutical giant Bristol-Myers Squibb (BMS) and its partner AstraZeneca (AZ) acquired the important biotech company Amylin for a cool $7 billion, which we...

Exercise and weight loss have been shown to significantly reduce a person’s risk of moving from prediabetes to type 2 diabetes. However, insurance coverage for these...

Adam discovers why sleep is critical to diabetes control.

In January, the FDA announced the approval of three of Takeda’s new once-daily DPP-4 inhibitor pills for type 2 diabetes. DPP-4 inhibitors have been the best-selling...

Kelly on 26 years of living with diabetes and “what I wish I had known...”

On November 14, World Diabetes Day was commemorated at 574 blue-lit monuments around the world. The annual event is meant to be a rallying experience for the global...

Highlights from the TCOYD newsletter.

Why did Qnexa become Qsymia? diaTribe investigates the thinking behind drug names… and why they’re vital to patient safety.

How can the FDA change its view on drug approvals to give patients access to better therapies?

On December 11, Omada Health launched Prevent Now , an online version of the Diabetes Prevention Program (DPP). The landmark NIH-funded DPP study found that moderate...

A candid interview with diaTribe advisory board member Dr. Anne Peters touches on the newest drugs and devices, curing type 1, and addressing obesity.

On July 13, Johnson & Johnson acquired Calibra Medical , maker of the Finesse “insulin patch-pen” for type 1 and type 2 diabetes. The slimly designed Finesse (2...

On August 17, the FDA approved Mylan’s new generic versions of Actos (pioglitazone), a once-daily oral tablet for the treatment of type 2 diabetes originally sold by...